| mRNA |
EX-527 |
CTRPv2 |
pan-cancer |
AAC |
0.005 |
0.9 |
| mRNA |
istradefylline |
CTRPv2 |
pan-cancer |
AAC |
-0.007 |
0.9 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0045 |
0.9 |
| mRNA |
Pazopanib |
GDSC1000 |
pan-cancer |
AAC |
-0.0044 |
0.9 |
| mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0042 |
0.9 |
| mRNA |
VX-680 |
GDSC1000 |
pan-cancer |
AAC |
0.0074 |
0.9 |
| mRNA |
XAV-939 |
GDSC1000 |
pan-cancer |
AAC |
0.0042 |
0.9 |
| mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.004 |
0.9 |
| mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0039 |
0.9 |
| mRNA |
BCL-LZH-4 |
CTRPv2 |
pan-cancer |
AAC |
-0.006 |
0.9 |